CMS 135 - Heart Failure: Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic
Views: 894
CMS 135 / Quality ID# 005
Percentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction (LVEF) <40% who were prescribed ACE inhibitor or ARB or ARNI therapy either within a 12-month period when seen in the outpatient setting or at each hospital discharge.
Denominator: | All patients aged 18 years and older who have had two or more qualifying encounters, one of which had a diagnosis of heart failure, and the remaining encounters had findings of moderate or severe LVSD findings (where the LVEF is less than 40%).
|
Numerator: | Patients who were prescribed ACE inhibitor or ARB therapy within 12-month period when in the outpatient setting.
|
Denominator Exceptions: |
|
Office Visit Documentation: |
Once all steps have been completed, the measure will be added to the Quality Measures Report. |
Measure type: | Process |
High Priority Measure: | No |
Telehealth Eligible: | Yes |